Lisata Therapeutics, Inc. (LSTA): Total Liabilities
$3.14M
As of 2025-12-31
$3.04M
As of 2026-06-30
-22.3%
3-year compound annual growth
-3.5%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.14M | -44.7% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $5.68M | -16.4% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $6.80M | +1.3% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $6.71M | +34.0% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $5.01M | +33.2% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $3.76M | -43.0% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $6.60M | -7.4% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $7.13M | -46.0% | 2020-03-05, Balance as of period end |
| 2017-12-31 | $13.19M | -56.1% | 2019-03-14, Balance as of period end |
| 2016-12-31 | $30.05M | n/a | 2018-03-22, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $3.14M | -44.7% |
| Clene Inc. (CLNN) | 2025-12-31 | $35.72M | -1.3% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $6.99M | +12.4% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $6.56M | +21.9% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $672.0K | +14.3% |
| iBio, Inc. (IBIO) | 2026-06-30 | $13.40M | +61.3% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $7.76M | +13.9% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $2.74M | -52.6% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $8.43M | -22.2% |
Compare LSTA, CLNN, SER, RGBP side by side · Screen every company in Pharmaceutical Preparations ↗